Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-129155

Options or other derivatives

  • Chief Legal Officer acquired 217,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bizily Scott Chief Legal Officer 2026-03-25 Grant or award · Stock Option (Right to Buy) +217,000 217,000 D
Loading xslF345X06/ownership.xml…